Psoriasis Tied to Increased Risk for Sleep Disorders
By Lori Solomon HealthDay Reporter
MONDAY, June 2, 2025 -- Both mild and moderate-to-severe psoriasis are significantly associated with an increased risk for sleep disorders, according to a study published online May 13 in JEADV Clinical Practice.
Michael J. Diaz, from the College of Medicine at the University of Florida in Gainesville, and colleagues quantified the extent to which psoriasis severity correlates with the risk for developing specific sleep disorders. The analysis included 7,743 adults with psoriasis identified from the All of Us database matched 1:4 to age-, sex-, and race/ethnicity-matched controls.
The researchers found that mild psoriasis was significantly associated with restless leg syndrome, insomnia, and obstructive sleep apnea when adjusting for sociodemographic variables and comorbidities. The associations were even stronger with moderate-to-severe psoriasis. The risk for sleep disorder was magnified in non-White patients, particularly for insomnia and obstructive sleep apnea.
"By highlighting these variations in a nationally diverse sample, we underscore the necessity for personalized, culturally sensitive approaches in the clinical management of psoriasis and its associated comorbidities," the authors write. "Study limitations include the use of electronic health records and potential for diagnostic misclassification."
Several authors disclosed ties to the biopharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted June 2025
Read this next
Central Adiposity Measures Associated With Psoriasis Risk
TUESDAY, June 3, 2025 -- Central adiposity measures are strongly associated with psoriasis risk, with a stronger association in women, according to a research letter published...
Culturally Tailored Intervention Beneficial for Latina Breast Cancer Survivors
MONDAY, June 2, 2025 -- A culturally tailored intervention for Latina breast cancer survivors (BCSs) yields clinically relevant but not statistically significant improvement in...
Trend Toward Survival Benefit Seen for REM-Inhibition in ALS
THURSDAY, May 22, 2025 -- For patients with amyotrophic lateral sclerosis (ALS), rapid eye movement (REM) inhibition via receipt of antidepressant medication is associated with a...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.